<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1320">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01993628</url>
  </required_header>
  <id_info>
    <org_study_id>5565</org_study_id>
    <nct_id>NCT01993628</nct_id>
  </id_info>
  <brief_title>Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))</brief_title>
  <official_title>Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <brief_summary>
    <textblock>
      Alzheimer's disease (AD) and Lewy body's dementia (LBD) are two frequent neurodegenerative&#xD;
      pathologies. They differ in their expression, their evolution but share same features which&#xD;
      make their diagnosis uneasy.&#xD;
&#xD;
      Constructional apraxia has been described in both disease.The underlying mechanisms have been&#xD;
      less studied and could be different in AD and LBD.&#xD;
&#xD;
      The definition of the constructional apraxia is purely descriptive and few models are&#xD;
      inconclusive.&#xD;
&#xD;
      It is admitted that drawing tasks involve visuo-perceptive and visuo-spatial abilities,&#xD;
      executive functions and working memory as well as purely &quot;constructive&quot; skills.&#xD;
&#xD;
      Regarding to different studies, visuo-perceptive abilities are more severely impaired in LBD&#xD;
      than in AD and are considered as an early onset sign of the disease.&#xD;
&#xD;
      Executive functions deficits are documented in AD and LDB and could contribute to the drawing&#xD;
      impairment.&#xD;
&#xD;
      It is possible to compensate the planning disorders in giving patient the best strategy to&#xD;
      use.&#xD;
&#xD;
      If drawing impairment persists, they should result of others mechanisms like&#xD;
      visuo-perception, visuo-spatial or constructive deficits.&#xD;
&#xD;
      The investigators suggest that giving the best planning strategy will help more AD patients&#xD;
      who are supposed to fail in raison of an executive impairment, than the LDB group who is&#xD;
      supposed to present visuo-perceptive deficits. An MRI will be proposed to study the cerebral&#xD;
      areas involved in constructional apraxia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score obtained at the Rey figure test with a planning strategy help by LBD patients compared to the score obtained by AD patients.</measure>
    <time_frame>At inclusion</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Alzheimer's Disease</condition>
  <condition>Lewy Body's Dementia</condition>
  <arm_group>
    <arm_group_label>Alzheimer's disease (AD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rey figure test and MRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lewy body's dementia (LBD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rey figure test and MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rey figure test</intervention_name>
    <arm_group_label>Alzheimer's disease (AD)</arm_group_label>
    <arm_group_label>Lewy body's dementia (LBD)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI</intervention_name>
    <arm_group_label>Alzheimer's disease (AD)</arm_group_label>
    <arm_group_label>Lewy body's dementia (LBD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Alzheimer's disease or Lewy bodies dementia&#xD;
&#xD;
          -  ≥ 45 years&#xD;
&#xD;
          -  the cognitive impairment is mild to moderate&#xD;
&#xD;
          -  French speaker&#xD;
&#xD;
          -  a caregiver is present&#xD;
&#xD;
          -  An informed consent is signed by the patient and the p.i.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  MRI contraindication&#xD;
&#xD;
          -  Other neurological disease (FTD, brain tumor, vascular disease…)&#xD;
&#xD;
          -  Psychiatric disease (Schizophrenia, major depression, psychotic disorders,&#xD;
             melancholia…)&#xD;
&#xD;
          -  Patient who doesn't want to be informed in case of the discovery of an abnormality&#xD;
&#xD;
          -  View or audition deficits, or motor disability which can interfere with the cognitive&#xD;
             testing&#xD;
&#xD;
          -  Patient participating to an exclusive protocol or in the period of exclusion&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Person under an administrative or legal measure of liberty privation&#xD;
&#xD;
          -  Person under a legal measure of protection or under administrative supervision&#xD;
&#xD;
          -  Person unable to give his consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xavier DE PETIGNY, Docteur</last_name>
    <phone>3 88 11 56 24</phone>
    <phone_ext>0033</phone_ext>
    <email>xavier.depetigny@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>PHILLIPPS Clelie, Ingenior</last_name>
    <phone>3 88 12 79 25</phone>
    <phone_ext>0033</phone_ext>
    <email>clelie.phillipps@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier De Pétigny, Docteur</last_name>
      <phone>3 88 12 79 25</phone>
      <phone_ext>0033</phone_ext>
      <email>xavier.depetigny@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>October 31, 2013</study_first_submitted>
  <study_first_submitted_qc>November 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>November 18, 2013</last_update_submitted>
  <last_update_submitted_qc>November 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Apraxias</mesh_term>
    <mesh_term>Lewy Body Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

